SU1515606A1 - Method of purification and isolation of sodium nitroprusside - Google Patents

Method of purification and isolation of sodium nitroprusside

Info

Publication number
SU1515606A1
SU1515606A1 SU4353496/02A SU4353496A SU1515606A1 SU 1515606 A1 SU1515606 A1 SU 1515606A1 SU 4353496/02 A SU4353496/02 A SU 4353496/02A SU 4353496 A SU4353496 A SU 4353496A SU 1515606 A1 SU1515606 A1 SU 1515606A1
Authority
SU
USSR - Soviet Union
Prior art keywords
sodium nitroprusside
isolation
purification
solution
dissolving
Prior art date
Application number
SU4353496/02A
Other languages
Russian (ru)
Inventor
С.Я. Скачилова
Г.А. Ермакова
Т.С. Сафонова
Ф.А. Саяпина
Л.Б. Алтухова
М.И. Фелицина
И.И. Тюляев
В.А. Быков
Н.А. Ващенкова
Original Assignee
Научно-исследовательский институт технологии и безопасности лекарственных средств
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Научно-исследовательский институт технологии и безопасности лекарственных средств filed Critical Научно-исследовательский институт технологии и безопасности лекарственных средств
Priority to SU4353496/02A priority Critical patent/SU1515606A1/en
Application granted granted Critical
Publication of SU1515606A1 publication Critical patent/SU1515606A1/en

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

FIELD: medicinal agents. SUBSTANCE: isolation and purification of sodium nitroprusside is carried out by sodium nitroprusside dissolving in acidified water or aqueous-spirituous solution using tertiary aminoalcohols as stabilizing agent at concentration 0.5-1% Prepared solution is purified with activated carbon, and the following isolation of sodium nitroprusside is performed with low-molecular aliphatic alcohol. EFFECT: increased yield and quality of product.
SU4353496/02A 1987-12-30 1987-12-30 Method of purification and isolation of sodium nitroprusside SU1515606A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SU4353496/02A SU1515606A1 (en) 1987-12-30 1987-12-30 Method of purification and isolation of sodium nitroprusside

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SU4353496/02A SU1515606A1 (en) 1987-12-30 1987-12-30 Method of purification and isolation of sodium nitroprusside

Publications (1)

Publication Number Publication Date
SU1515606A1 true SU1515606A1 (en) 1995-08-09

Family

ID=60519795

Family Applications (1)

Application Number Title Priority Date Filing Date
SU4353496/02A SU1515606A1 (en) 1987-12-30 1987-12-30 Method of purification and isolation of sodium nitroprusside

Country Status (1)

Country Link
SU (1) SU1515606A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110615448A (en) * 2018-06-20 2019-12-27 四川科瑞德凯华制药有限公司 Method for preparing sodium nitroprusside
US11312839B2 (en) * 2018-03-16 2022-04-26 Hf Scientific, Llc Method and composition for preserving sodium nitroprusside solutions

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11312839B2 (en) * 2018-03-16 2022-04-26 Hf Scientific, Llc Method and composition for preserving sodium nitroprusside solutions
CN110615448A (en) * 2018-06-20 2019-12-27 四川科瑞德凯华制药有限公司 Method for preparing sodium nitroprusside

Similar Documents

Publication Publication Date Title
MA19639A1 (en) Process for the preparation of derivatives of cis, endo-2-azabicyclo- (3,3,0) -octane-3-carboxylic acid and agents containing these derivatives
UA41446C2 (en) Use of fumagilol or its derivatives for preparing drugs intended for treating intestinal infection and pharmaceutical composition
KR880701738A (en) Modification of alginate or tauronic acid by CO₂ treatment
ES8200082A1 (en) Process for the preparation of a sterile injectable physiologically acceptable solution of an X-ray contrast agent and solutions of the X-ray contrast agent and a buffer
DK617086D0 (en) ANTIBIOTIC A 40926 MANNOSYL-AGLYCON AND ITS ADDITIONAL SALTS AND MEDICINAL PRODUCTS CONTAINING SUCH A LINK
GR3004869T3 (en)
ES522637A0 (en) PROCEDURE FOR THE PREPARATION OF NEW SUBSTANCES WS 6049.
ES8607916A1 (en) Biscarboxamides for treating diseases, and process for their preparation.
ES8302090A1 (en) Antibiotic BMG162-aF2, a process for production thereof, and antitumor drug containing said new antibiotic as active ingredient
ES8301244A1 (en) Sisomicin derivatives, process for their preparation and their use as pharmaceutical compositions.
SU1515606A1 (en) Method of purification and isolation of sodium nitroprusside
UA13377A (en) Method for preparing antiviral composition
ZA814234B (en) 1-s-alkyl-2-0-acyl-3-phosphocholine-1-mercapto-2.3-propandiols process for producing the same and pharmaceutical preparations containing the same
UA14449A1 (en) Process for preparation of pantocrine
JPS5799198A (en) Preparation of l-phenylalanine
IT1252228B (en) PROCEDURE FOR THE PRODUCTION OF NEURAMINIDASE
UA14451A1 (en) Process for preparation of pantocrine for injections
JPS5495795A (en) Production of interferon
DE3574675D1 (en) METHOD FOR STERILIZING RECOMBINANT MICROORGANISM.
DE68920269D1 (en) Process for the preparation of human tissue plasminogen activator.
JPS5257129A (en) Process for hydroquinone
GB1312129A (en) Antibiotic and process for preparing same
GB1377292A (en) Process for the purification of streptomycin
JPS55150900A (en) Production of interferon
SU1522498A1 (en) Disinfecting agent